Abstract
Statin use for cancer may be a potential protective effect in patients with chronic hepatitis B virus infection, according to our research. Statin use reduced the associated risk of liver cancer. With people eating westernized in Taiwan, the use of statins increases year by year. In addition to prevention of cardiovascular disease, also for patients with chronic hepatitis on the preventive effect of hepatocellular carcinoma, the economic benefits of statin use is worth studying. We used the National Health insurance data to explore so far, the statin use since 1997 and the clinical efficacy, including adverse effects. According to the results of our study, statin use for HCC had a potential protective effect in patients with chronic hepatitis B virus infection. Statin use reduced the associated risk of HCC, in particular, our studies found that statin use significantly reduced risk of HCC with cost-effectiveness.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425–430
Keyomarsi K, Sandoval L, Band V et al (1991) Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res 51:3602–3609
Kusama T, Mukai M, Iwasaki T et al (2002) 3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis. Gastroenterology 122:308–317
Weis M, Heeschen C, Glassford AJ et al (2002) Statins have biphasic effects on angiogenesis. Circulation 105:739–745
Gauthaman K, Fong CY, Bongso A (2009) Statins, stem cells, and cancer. J Cell Biochem 106:975–983
Chan KK, Oza AM, Siu LL (2003) The statins as anticancer agents. Clin Cancer Res 9:10–19
Dimitroulakos J, Marhin WH, Tokunaga J et al (2002) Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas. Neoplasia 4:337–346
Jacobs EJ, Newton CC, Thun MJ et al (2011) Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States Cohort. Cancer Res 71:1763–1771
Friis S, Poulsen AH, Johnsen SP et al (2005) Cancer risk among statin users: A population-based cohort study. Int J Cancer 114:643–647
Poynter JN, Gruber SB, Higgins PD et al (2005) Statins and the risk of colorectal cancer. N Engl J Med 352:2184–2192
Karp I, Behlouli H, Lelorier J et al (2008) Statins and cancer risk. Am J Med 121:302–309
Research, N. H. R. I. N. H. I., database. http://www.nhri.org.tw/nhird/date_01.html#_edn1. Accessed 1 Jan 2012
Centers for Disease Control and Prevention, Atlanta, Georgia (1979) International Classification of Diseases, Ninth Revision (ICD-9). http://www.cdc.gov/nchs/icd/icd9.htm. Accessed 10 Jan 2012
Khan BH (2000) A framework for web-based learning. Educational Technology Publications, Englewood Cliffs
Liaw S-S, Huang H-M, Chen G-D (2007) Surveying instructor and learner attitudes toward e-learning. Comput Educ 49:1066–1080
Wang Y-S, Wang H-Y, Shee DY (2007) Measuring e-learning systems success in an organizational context: scale development and validation. Comput Hum Behav 23:1792–1808
Chikh A, Berkani L (2010) Communities of practice of e-learning, an innovative learning space for e-learning actors. Procedia Soc Behav Sci 2:5022–5027
Sultan N (2010) Cloud computing for education: a new dawn? Int J Inf Manage 30:109–116
Arshad J, Townend P, Xu J (2011) A novel intrusion severity analysis approach for Clouds. Future Gener Comput Sys. doi:10.1016/j.future.2011.08.009
Loganayagi B, Sujatha S (2012) Enhanced cloud security by combining virtualization and policy monitoring techniques. Procedia Eng 30:654–661
Baigent C, Keech A, Kearney PM et al (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366:1267–1278
Hebert PR, Gaziano JM, Chan KS et al (1997) Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 278:313–321
Kjekshus J, Apetrei E, Barrios V et al (2007) Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357:2248–2261
Amarenco P, Bogousslavsky J, Callahan A 3rd et al (2006) High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355:549–559
Sassano A, Platanias LC (2008) Statins in tumor suppression. Cancer Lett 260:11–19
Newman TB, Hulley SB (1996) Carcinogenicity of lipid-lowering drugs. JAMA 55–60
Wong WW, Dimitroulakos J, Minden MD et al (2002) HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 16:508–519
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Singapore
About this paper
Cite this paper
Tsan, YT., Chan, YW., Chan, WC., Lin, CH. (2016). Cost Analysis Between Statins and Hepatocellular Carcinoma by Using Data Mining Approach. In: Hung, J., Yen, N., Li, KC. (eds) Frontier Computing. Lecture Notes in Electrical Engineering, vol 375. Springer, Singapore. https://doi.org/10.1007/978-981-10-0539-8_60
Download citation
DOI: https://doi.org/10.1007/978-981-10-0539-8_60
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-0538-1
Online ISBN: 978-981-10-0539-8
eBook Packages: Computer ScienceComputer Science (R0)